D_Purchase Description.pdf

PDF 184 KB Posted

Attached to
Isoplexis IsoSpark Duo Federal contract opportunity
Solicitation number
75N95022Q00329
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

View the file

Other files for this federal contract opportunity

Other files attached to Isoplexis IsoSpark Duo, newest first.
File Type Posted
D_FAR 52.204-26_Oct_2020.pdf PDF
D_FAR 52.212-4 Addendum.pdf PDF
D_FAR 52.204-24 (Nov 2021).pdf PDF
D_Invoicing Instructions Without IPP_04212022.pdf PDF
D_FAR 52.212-5 (May 2022) FILLABLE 5-1-2022.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

1. Statement of Need and Purpose: The purpose of this request is to purchase IsoSpark Duo from Isoplexis.

2. Background Information and Objective: The central hypothesis of this project is that immune dysfunction contributes directly to chronic inflammation and inflammation-associated diseases in the elderly. To understand the basis for immune impairment that accompanies aging, we propose to identify age-associated alterations in human innate and adaptive immune cell populations. Towards this goal, we will carry out cross-sectional analysis of proteomes at single cell levels from various immune cell subsets obtained from peripheral blood of 50 participants. Our major objectives are to identify age-associated changes in these parameters in each cell type and to determine how characteristics in a specific cell type change depending on the cellular milieu. Isoplexis technology will provide significant insigts on all the aspect of of hypothesis.

3. Generic Name of Product: Isoplexis IsoSpark Duo

4. Purchase Description:

1- IsoSpark Duo; Product Code # ISOSPARK-1001-1 2- Instalation and training; Product Code # SVCISL-INST-1

5. Salient characteristics:

1- IsoSpark Duo is cutting edge single cell proteome analysis technology.

2- Single instrument platform is capable of performing single-cell proteome, single-cell intracellular signaling, and single-cell metabolomics.

3- Platform is capable of perofming Secretome and fluids (serum/plasma) proteomics.

4- Ready-to-use reagents and Chips.

6. Quantity:

1- IsoSpark Duo: 1 2- Instalation and training: 1

7. Delivery Date: within 30 days from placing the order.

Delivery shall be made to

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

Mary Kaileh Building: BRC, Room: 6C211A National Institute of Aging 215 Bayview Blvd Baltimore, MD 21224

File details come from the government source that posted it. Updated .